跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NITISINONE TABLETS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NITISINONE TABLETS
Authorized
STANDARD
NITISINONE TABLETS
Cycle Pharmaceuticals Ltd.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
41cd16d01ee5eeaf
Company
Cycle Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
41cd16d01ee5eeaf
Drug Approval Canada Name
NITISINONE TABLETS
Product Name
NITISINONE TABLETS
Status
Marketed
Status Date
2017-01-13
Original Market Date
2017-01-13
Din
02458624
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:92.00
Atc Original
A16AX04 NITISINONE
Atc Name
a 16 ax 04
Aig Number
0158450002
Company Name
Cycle Pharmaceuticals Ltd.
Company Address
Broers Building, 21 Jj Thomson Ave., Cambridge, Cambridgeshire, United Kingdom, CB3 0FA
Company Detail Path
/organization/cycle-pharmaceuticals-ltd
Company Information
Pharmaceutical Company Name
Cycle Pharmaceuticals Ltd.
Country Name
United States
Province Name
Massachusetts
City Name
马萨诸塞州米德尔塞克斯县
Website
http://www.cyclepharma.com
Active Ingredients
NITISINONE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
41cd16d01ee5eeaf
Type
Standard
Back to Health Canada Approvals